Chronic pelvic pain and endometriosis in adolescents

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue 5, 2006, Pages 511-518

  Solnik, Meir Jonathon ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Adolescent; Endometriosis; Pelvic pain; Treatment

Indexed keywords

ALPHA TOCOPHEROL; ANASTROZOLE; AROMATASE INHIBITOR; ASOPRISNIL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOOXYGENASE 2 INHIBITOR; CYPROTERONE ACETATE; DANAZOL; ESTRADIOL; GONADORELIN AGONIST; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

ADENOMYOSIS; ADNEXA DISEASE; ADOLESCENCE; ALGORITHM; ALTERNATIVE MEDICINE; APPENDICITIS; BREAST DEVELOPMENT; CLINICAL EXAMINATION; CLINICAL TRIAL; CONSTIPATION; CYSTITIS; DEPRESSION; DIAGNOSTIC TEST; DIARRHEA; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; ESTROGEN DEFICIENCY; HERNIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INCIDENCE; INTERSTITIAL CYSTITIS; INTESTINE INJURY; INTRAUTERINE CONTRACEPTIVE DEVICE; IRRITABLE COLON; LAPAROSCOPIC SURGERY; MORBIDITY; MUELLERIAN DUCT; MYALGIA; NEURECTOMY; OSTEOLYSIS; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; PERITONEUM ADHESION; PHYSIOTHERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; SIDE EFFECT; SYMPTOM; ULTRASOUND; VIRILIZATION;

ADOLESCENT; CHRONIC DISEASE; ENDOMETRIOSIS; FEMALE; HUMANS; PATIENT SELECTION; PELVIC PAIN; TREATMENT OUTCOME;

EID: 33748256302     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000242953.94749.2b     Document Type: Review

References (62)

1. Mathias SD, Kuppermann M, Liberman F, et al. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996; 87:321-327.
2. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001; 14:3-8.
3. Howard FM. Chronic pelvic pain. Obstet Gynecol 2003; 101:594-611.
4. Holland-Hall CM, Brown RT. Evaluation of the adolescent with chronic abdominal or pelvic pain. J Pediatr Adolesc Gynecol 2004; 17:23-27.
5. Wolfman WL, Kreutner K. Laparoscopy in children and adolescents. J Adolesc Health Care 1984; 5:261-265.
6. Schroder B, Sanfilippo JS, Hertweck SP. Musculoskeletal pelvic pain in a pediatric and adolescent gynecology practice. J Pediatr Adolesc Gynecol 2000; 13:90.
7. Tu FF, As-Sanie S, Steege JF. Musculoskeletal causes of chronic pelvic pain. J Reprod Med 2006; 51:185-189. The authors validate pelvic floor myalgia as a common cause for chronic pelvic pain. There are few publications specific to this topic.
8. Jarvis SK, Abbott JA, Lenart MB, et al. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol 2004; 44:46-50.
9. Meigs JV. Endometriosis. Ann Surg 1948; 127:795.
10. Fallon J. Endometriosis in youth. JAMA 1946; 131:1405-1406.
11. Reese KA, Reddy S, Rock JA. Endometriosis in an adolescent population: the Emory experience. J Pediatr Adolesc Gynecol 1996; 9:125-128.
12. Stavroulis AI, Saridogan E, Creighton SM, et al. Laparoscopic treatment of endometriosis in teenagers. Eur J Obstet Gynecol Reprod Biol 2006; 125:248-250. The most recent surgical review of endometriosis in adolescents. The authors provide further evidence for significantly advanced disease in adolescents, with a positive response to surgical resection.
13. Laufer MR, Goitein BA, Bush M, et al. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997; 10:199-202.
14. Wheeler J. Epidemiology of endometriosis-associated infertility. J Reprod Med 1989; 34:41-46.
15. Sampson JA. The development of the implantation theory for the origin of peritoneal endometriosis. Am J Obstet Gynecol 1940; 40:549-557.
16. Schifrin BS, Erez S, Moore JG. Teen-age endometriosis. Am J Obstet Gynecol 1973; 116:973-980.
17. Goldstein DP, de Cholnoky C, Emans SJ. Adolescent endometriosis. J Adolesc Health Care 1980; 1:37-41.
18. Sanfilippo JS, Wakim NG, Schikler KN, et al. Endometriosis in association with uterine anomaly. Am J Obstet Gynecol 1986; 154:39-43.
19. Marsh EE, Laufer MR. Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly. Fertil Steril 2005; 83:758-760.
20. Batt RE, Smith RA. Embryologic theory of histogenesis of endometriosis in peritoneal pockets. Obstet Gynecol Clin North Am 1989; 16:15-28.
21. Halme J, Becker S, Hammond MG, et al. Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am J Obstet Gynecol 1983; 145:333-337.
22. Lin YJ, Lai MD, Lei HY, et al. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 2006; 147:1278-1286.
23. Antsiferova YS, Sotnikova NY, Posiseeva LV, et al. Changes in T-helper cytokine profile and in lymphocyte activation at the system and local levels in women with endometriosis. Fertil Steril 2005; 84:1705-1711.
24. Sinaii N, Cleary SD, Ballweg ML, et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002; 17:2715-2724.
25. Jackson LW, Schisterman EF, Dey-Rao R, et al. Oxidative stress and endometriosis. Hum Reprod 2005; 20:2014-2020.
26. Bischoff F, Simpson JL. Genetic basis of endometriosis. Ann N Y Acad Sci 2004; 1034:284-299.
27. Simpson JL, Elias S, Malinak LR, et al. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980; 137:327-331.
28. Huber A, Keck CC, Lukas HA, et al. Ten estrogen-related polymorphisms and endometriosis. Obstet Gynecol 2005; 106:1025-1031.
29. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001; 14:3-8.
30. Goldstein DP, De Cholnoky C. Adolescent endometriosis. J Adolesc Health Care 1980; 1:37-41.
31. Davis GD, Thillet E, Lindemann J. Clinical characteristics of adolescent endometriosis. J Adolesc Health 1993; 14:362-368.
32. Koninckx PR, Meuleman C, Demeyere S, et al. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991; 55:759-765.
33. Ziereisen F, Guissard G, Damry N, et al. Sonographic imaging of the paediatric female pelvis. Eur Radiol 2005; 15:1296-1309. This article provides background information regarding radiographic tools used to image the female pelvis from prepubertal years to adolescence. Selective pathology is further reviewed.
34. Hediter ML, Hartnett HJ, Louis GM. Association of endometriosis and body size and figure. Fertil Steril 2005; 84:1366-1374. Patient demographics may help physicians target those more susceptible to endometriosis, allowing them to focus their evaluation. This paper provides sufficient evidence for low body mass index as a consistent characteristic.
35. Ballweg ML. Big picture of endometriosis helps provide guidance on approach to teens: comparative historical data show endo starting younger, is more severe. J Pediatr Adolesc Gynecol 2003; 16:S21-S26.
36. Arruda MS, Petta CA, Abrao MS, et al. Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women. Hum Reprod 2003; 18:756-759.
37. American College of Obstetricians and Gynecologists. Endometriosis in adolescents: ACOG committee opinion no. 310. Obstet Gynecol 2005; 105:921-927. A comprehensive review of management strategies for adolescent endometriosis that was proposed by the American College of Obstetricians and Gynecologists Committee on Adolescent Health Care.
38. Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2000; 2:CD001019.
39. Davis AR, Westhoff C, O'Connell K, et al. Oral contraceptives for dysmenorrhea in adolescent girls. Obstet Gynecol 2005; 106:97-104. The only randomized trial comparing treatment modalities for dysmenorrhea in adolescents. Recruitment was based on symptoms and not surgical or pathologic diagnoses.
40. Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev 2003; 4:CD001751.
41. Daniels SE, Talwalker S, Torri S, et al. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. Obstet Gynecol 2002; 100:350-358.
42. Ota H, Igarashi S, Sasaki M, et al. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001; 16:561-566.
43. Prentice A, Deary AJ, Bland E. Progestagens and antiprogestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2003; 2:CD002122.
44. Cromer BA, Blair JM, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 1996; 129:671-676.
45. Matkovic V, Jelic T, Wardlaw G, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis: inference from a cross-sectional model. J Clin Invest 1994; 93:799-808.
46. Merki-Field GS, Neff M, Keller PJ. A 2-year prospective study on the effects of depot medroxyprogesterone acetate on bone mass: response to estrogen and calcium therapy in individual users. Contraception 2003; 67:79-86.
47. Crosignani PG, Luciano A, Ray A, et al. Subcutaneous depot medroxyprogesterone acetate versus depot leuprolide in the treatment of endometriosis-associated pain. Hum Reprod 2006; 21:248-256. This is a well designed randomized trial that evaluated DMPA administered subcutaneously. The authors found this regimen to be as efficacious as a GnRH agonist for treating symptomatic endometriosis, without adverse effects on BMD.
48. Agarwal SK. Impact of six months of GnRH agonist therapy for endometriosis: is there an age-related effect on bone mineral density? J Reprod Med 2002; 47:530-534.
49. Lubianca JN, Gordon CM, Laufer MR. "Add-back" therapy for endometriosis in adolescents. J Reprod Med 1998; 43:164-172.
50. Surrey ES, Hornstein MD. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow up. Obstet Gynecol 2002; 99:709-719.
51. Nabholta JM, Buzdar A, Pollak M, et al. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. J Clin Oncol 2000; 18:3758-3767.
52. Kitawaki J, Kusuki I, Koshiba H, et al. Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 1999; 72:1100-1106.
53. Amsterdam LL, Gentry W, Jobanputra S, et al. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005; 84:300-304. This is a report from a Food and Drug Administration phase II trial that provides early evidence for use of aromatase inhibitors in the setting of endometriosis. The findings do not apply to adolescents.
54. Chwalisz K, Perez MC, DeManno D, et al. Selective progesterone receptor modulator development and use in the treatment of leiyomyomata and endometriosis. Endocr Rev 2005; 26:423-438. A comprehensive review of the molecular basis for SPRMs for the treatment of two steroid hormone-dependent disorders.
55. Chwalisz K, Mattia-Goldberg K, Lee M, et al. Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil. Fertil Steril 2004; 82:S83.
56. Harris HA, Bruner-Tran KL, Zhang X, et al. A selective estrogen receptor-b agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 2005; 20:936-941.
57. Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005; 20:1993-1998. The only randomized trial to evaluate the progestin-containing intrauterine device in the setting of endometriosis. Its use may be limited to adults.
58. Proctor M, Farquhar C. Dysmenorrhoea. Clin Evid 2002; 7:1639-1653.
59. Jacobson TZ, Barlow DH, Garry R, et al. Laparoscopic surgery for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2001; 4:CD001300.
60. Marcoux S, Rodolphe M, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med 1997; 337:217-222.
61. Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis. Cochrane Database Syst Rev 2004; 3:CD003678.
62. Ugur M, Turan C, Mungan T, et al. Endometriosis in association with müllerian anomalies. Gynecol Obstet Invest 1995; 40:261-264.